Powered By
Below is a listing of treatments and therapies for HAE. Click on one to read more information or connect with others currently using it.
Andembry (garadacimab-gxii) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent hereditary angioedema (HAE) attacks in adults and children…
read moreBerinert (C1 esterase inhibitor [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute abdominal, facial, or throat swelling attacks…
read moreCinryze (C1 esterase inhibitor [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent hereditary angioedema (HAE) attacks in adults and…
read moreDawnzera (donidalorsen) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent hereditary angioedema (HAE) attacks in adults and children 12 years…
read moreEkterly (sebetralstat) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute attacks of hereditary angioedema (HAE) in adults and children ages…
read moreFirazyr (icatibant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat sudden attacks of hereditary angioedema (HAE) in adults 18 years of age and…
read moreHaegarda (C1 esterase inhibitor subcutaneous [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for routine prevention of hereditary angioedema (HAE)…
read moreKalbitor (ecallantide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat sudden attacks of hereditary angioedema (HAE) in people ages 12 and…
read moreOrladeyo (berotralstat) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent attacks of hereditary angioedema (HAE) in adults and children ages 2 and…
read moreRuconest (C1 esterase inhibitor [recombinant]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat sudden attacks of hereditary angioedema (HAE) in…
read moreTakhzyro (lanadelumab-flyo) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent hereditary angioedema (HAE) attacks in adults and children ages 2…
read moreBecome a member to get even more
Join
Your Privacy Choices
